Barr Laboratory BRL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Barr Laboratory BRL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: harkenman who wrote (82)	10/25/1997 11:27:00 AM
From: James Silverman	of 207

Hark-They reported stellar earnings, yet the stock is still a moderate amount below highs. Perhaps as they gain in visibility (nearly a $1B market cap) and after a quarter or two of additional ramped up profitability and once investors realize much of this will be durable earnings and not standard generic variety the stock will follow suit and break new ground. I'm looking for the stock to do as well over the next year as it has thus far this year (100%+ytd), I'm far from complaining. As far as profitable generics out there, I think you are missing quite a few. Namely WPI, TEVIY and ADRX (will be highly profitable in 1998) each of which are serious companies.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next